BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nibourg GA, Chamuleau RA, van Gulik TM, Hoekstra R. Proliferative human cell sources applied as biocomponent in bioartificial livers: a review. Expert Opinion on Biological Therapy 2012;12:905-21. [DOI: 10.1517/14712598.2012.685714] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
Number Citing Articles
1 Williams DP. Modeling hepatic drug metabolism and toxicity: where are we heading? Future Med Chem 2014;6:725-7. [PMID: 24941867 DOI: 10.4155/fmc.14.31] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
2 Pluta KD, Samluk A, Wencel A, Zakrzewska KE, Gora M, Burzynska B, Ciezkowska M, Motyl J, Pijanowska DG. Genetically modified C3A cells with restored urea cycle for improved bioartificial liver. Biocybernetics and Biomedical Engineering 2020;40:378-87. [DOI: 10.1016/j.bbe.2019.12.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
3 Štampar M, Sedighi Frandsen H, Rogowska-Wrzesinska A, Wrzesinski K, Filipič M, Žegura B. Hepatocellular carcinoma (HepG2/C3A) cell-based 3D model for genotoxicity testing of chemicals. Sci Total Environ 2021;755:143255. [PMID: 33187710 DOI: 10.1016/j.scitotenv.2020.143255] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
4 Baquerizo A, Bañares R, Saliba F. Current Clinical Status of the Extracorporeal Liver Support Devices. Transplantation of the Liver. Elsevier; 2015. pp. 1463-87. [DOI: 10.1016/b978-1-4557-0268-8.00107-x] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
5 Selden C, Spearman CW, Kahn D, Miller M, Figaji A, Erro E, Bundy J, Massie I, Chalmers SA, Arendse H, Gautier A, Sharratt P, Fuller B, Hodgson H. Evaluation of encapsulated liver cell spheroids in a fluidised-bed bioartificial liver for treatment of ischaemic acute liver failure in pigs in a translational setting. PLoS One. 2013;8:e82312. [PMID: 24367515 DOI: 10.1371/journal.pone.0082312] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
6 van Wenum M, Adam AA, Hakvoort TB, Hendriks EJ, Shevchenko V, van Gulik TM, Chamuleau RA, Hoekstra R. Selecting Cells for Bioartificial Liver Devices and the Importance of a 3D Culture Environment: A Functional Comparison between the HepaRG and C3A Cell Lines. Int J Biol Sci 2016;12:964-78. [PMID: 27489500 DOI: 10.7150/ijbs.15165] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 4.8] [Reference Citation Analysis]
7 Ashraf MN, Asghar MW, Rong Y, Doschak MR, Kiang TKL. Advanced In Vitro HepaRG Culture Systems for Xenobiotic Metabolism and Toxicity Characterization. Eur J Drug Metab Pharmacokinet 2019;44:437-58. [DOI: 10.1007/s13318-018-0533-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
8 Ibrahim B, Stange J, Dominik A, Sauer M, Doss S, Eggert M. Albumin promotes proliferation of G1 arrested serum starved hepatocellular carcinoma cells. PeerJ 2020;8:e8568. [PMID: 32185103 DOI: 10.7717/peerj.8568] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Green CJ, Parry SA, Gunn PJ, Ceresa CDL, Rosqvist F, Piché ME, Hodson L. Studying non-alcoholic fatty liver disease: the ins and outs of in vivo, ex vivo and in vitro human models. Horm Mol Biol Clin Investig 2018;41:/j/hmbci. [PMID: 30098284 DOI: 10.1515/hmbci-2018-0038] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
10 Green CJ, Pramfalk C, Morten KJ, Hodson L. From whole body to cellular models of hepatic triglyceride metabolism: man has got to know his limitations. Am J Physiol Endocrinol Metab 2015;308:E1-20. [PMID: 25352434 DOI: 10.1152/ajpendo.00192.2014] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
11 van der Mark VA, Adam AAA, Chang JC, Oude Elferink RP, Chamuleau RAFM, Hoekstra R. Overexpression of the constitutive androstane receptor and shaken 3D-culturing increase biotransformation and oxidative phosphorylation and sensitivity to mitochondrial amiodarone toxicity of HepaRG cells. Toxicol Appl Pharmacol 2020;399:115055. [PMID: 32428594 DOI: 10.1016/j.taap.2020.115055] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Reiniers MJ, de Haan LR, Reeskamp LF, Broekgaarden M, van Golen RF, Heger M. Analysis and Optimization of Conditions for the Use of 2',7'-Dichlorofluorescein Diacetate in Cultured Hepatocytes. Antioxidants (Basel) 2021;10:674. [PMID: 33925917 DOI: 10.3390/antiox10050674] [Reference Citation Analysis]
13 Starokozhko V, Groothuis GMM. Challenges on the road to a multicellular bioartificial liver. J Tissue Eng Regen Med 2018;12:e227-36. [PMID: 27943623 DOI: 10.1002/term.2385] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
14 Jiang J, Wolters JE, van Breda SG, Kleinjans JC, de Kok TM. Development of novel tools for the in vitro investigation of drug-induced liver injury. Expert Opin Drug Metab Toxicol. 2015;11:1523-1537. [PMID: 26155718 DOI: 10.1517/17425255.2015.1065814] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 4.7] [Reference Citation Analysis]
15 Fang SY, Hu CQ, Liu MN, Tao L, Wang Y, Gong MJ, He Y, He TC, Bi Y. Reversibly immortalized hepatic progenitor cell line containing double suicide genes. Int J Mol Med 2018;42:1977-86. [PMID: 30085335 DOI: 10.3892/ijmm.2018.3803] [Reference Citation Analysis]
16 Higuchi Y, Kawai K, Yamazaki H, Nakamura M, Bree F, Guguen-Guillouzo C, Suemizu H. The human hepatic cell line HepaRG as a possible cell source for the generation of humanized liver TK-NOG mice. Xenobiotica 2014;44:146-53. [PMID: 24066694 DOI: 10.3109/00498254.2013.836257] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
17 Starokozhko V, Hemmingsen M, Larsen L, Mohanty S, Merema M, Pimentel RC, Wolff A, Emnéus J, Aspegren A, Groothuis G, Dufva M. Differentiation of human-induced pluripotent stem cell under flow conditions to mature hepatocytes for liver tissue engineering. J Tissue Eng Regen Med 2018;12:1273-84. [PMID: 29499107 DOI: 10.1002/term.2659] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
18 Hannoun Z, Steichen C, Dianat N, Weber A, Dubart-Kupperschmitt A. The potential of induced pluripotent stem cell derived hepatocytes. J Hepatol. 2016;65:182-199. [PMID: 26916529 DOI: 10.1016/j.jhep.2016.02.025] [Cited by in Crossref: 57] [Cited by in F6Publishing: 57] [Article Influence: 9.5] [Reference Citation Analysis]
19 Gaskell H, Sharma P, Colley HE, Murdoch C, Williams DP, Webb SD. Characterization of a functional C3A liver spheroid model. Toxicol Res (Camb) 2016;5:1053-65. [PMID: 27746894 DOI: 10.1039/c6tx00101g] [Cited by in Crossref: 55] [Cited by in F6Publishing: 24] [Article Influence: 9.2] [Reference Citation Analysis]
20 Ramboer E, De Craene B, De Kock J, Vanhaecke T, Berx G, Rogiers V, Vinken M. Strategies for immortalization of primary hepatocytes.J Hepatol. 2014;61:925-943. [PMID: 24911463 DOI: 10.1016/j.jhep.2014.05.046] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 6.9] [Reference Citation Analysis]
21 Hoshiba T, Otaki T, Nemoto E, Maruyama H, Tanaka M. Blood-Compatible Polymer for Hepatocyte Culture with High Hepatocyte-Specific Functions toward Bioartificial Liver Development. ACS Appl Mater Interfaces 2015;7:18096-103. [PMID: 26258689 DOI: 10.1021/acsami.5b05210] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
22 Hindley CJ, Cordero-Espinoza L, Huch M. Organoids from adult liver and pancreas: Stem cell biology and biomedical utility. Dev Biol 2016;420:251-61. [PMID: 27364469 DOI: 10.1016/j.ydbio.2016.06.039] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 6.3] [Reference Citation Analysis]
23 Adam AAA, van Wenum M, van der Mark VA, Jongejan A, Moerland PD, Houtkooper RH, Wanders RJA, Oude Elferink RP, Chamuleau RAFM, Hoekstra R. AMC-Bio-Artificial Liver culturing enhances mitochondrial biogenesis in human liver cell lines: The role of oxygen, medium perfusion and 3D configuration. Mitochondrion 2018;39:30-42. [PMID: 28844938 DOI: 10.1016/j.mito.2017.08.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
24 Hiller T, Berg J, Elomaa L, Röhrs V, Ullah I, Schaar K, Dietrich AC, Al-Zeer MA, Kurtz A, Hocke AC, Hippenstiel S, Fechner H, Weinhart M, Kurreck J. Generation of a 3D Liver Model Comprising Human Extracellular Matrix in an Alginate/Gelatin-Based Bioink by Extrusion Bioprinting for Infection and Transduction Studies. Int J Mol Sci 2018;19:E3129. [PMID: 30321994 DOI: 10.3390/ijms19103129] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 12.0] [Reference Citation Analysis]
25 Dianat N, Steichen C, Vallier L, Weber A, Dubart-Kupperschmitt A. Human pluripotent stem cells for modelling human liver diseases and cell therapy. Curr Gene Ther. 2013;13:120-132. [PMID: 23444872 DOI: 10.2174/1566523211313020006] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 4.8] [Reference Citation Analysis]
26 Gómez-Mariano G, Matamala N, Martínez S, Justo I, Marcacuzco A, Jimenez C, Monzón S, Cuesta I, Garfia C, Martínez MT, Huch M, Pérez de Castro I, Posada M, Janciauskiene S, Martínez-Delgado B. Liver organoids reproduce alpha-1 antitrypsin deficiency-related liver disease. Hepatol Int 2020;14:127-37. [PMID: 31832977 DOI: 10.1007/s12072-019-10007-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
27 Luce E, Messina A, Duclos-Vallée JC, Dubart-Kupperschmitt A. Advanced Techniques and Awaited Clinical Applications for Human Pluripotent Stem Cell Differentiation into Hepatocytes. Hepatology 2021;74:1101-16. [PMID: 33420753 DOI: 10.1002/hep.31705] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Adam AAA, van der Mark VA, Donkers JM, Wildenberg ME, Oude Elferink RPJ, Chamuleau RAFM, Hoekstra R. A practice-changing culture method relying on shaking substantially increases mitochondrial energy metabolism and functionality of human liver cell lines. PLoS One 2018;13:e0193664. [PMID: 29672606 DOI: 10.1371/journal.pone.0193664] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
29 Li ZH, Xie ZY, Ouyang XX, Huang KZ, Yu XP, Zhao YL, Zhang YH, Zhu DH, Yu J, Li LJ. Assessment of biological functions for C3A cells interacting with adverse environments of liver failure plasma. Hepatobiliary Pancreat Dis Int 2020;19:129-37. [PMID: 31704080 DOI: 10.1016/j.hbpd.2019.10.004] [Reference Citation Analysis]
30 van Wenum M, Chamuleau RA, van Gulik TM, Siliakus A, Seppen J, Hoekstra R. Bioartificial livers in vitro and in vivo : tailoring biocomponents to the expanding variety of applications. Expert Opinion on Biological Therapy 2014;14:1745-60. [DOI: 10.1517/14712598.2014.950651] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]